Global Chemoinformatics Market, By Product Type (Software, Services), Application (Chemical Analysis, Drug Discovery, Molecular Modeling, Regulatory Compliance, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes) – Industry Trends and Forecast to 2031.
Chemoinformatics Market Analysis and Size
Chemoinformatics involves using computational techniques to extract key information from chemical data, such as molecular structures and interactions. The market for chemoinformatics solutions has expanded significantly due to the growing demand for more efficient drug discovery and development processes in biotechnology and pharmaceutical industries. This field enables researchers to predict molecular properties, design new compounds, and analyze large datasets using advanced algorithms, machine learning, and data mining techniques.
Data Bridge Market Research analyses that the global chemoinformatics market, which was USD 5.29 billion in 2023, is expected to reach USD 19.23 billion by 2031, and is expected to undergo a CAGR of 15.87% during the forecast period of 2024-2031. This indicates the market value. “Software” dominates the product type segment of the Chemoinformatics market owing to advancements in software technology, increasing complexity of drug discovery, cost-effectiveness and growing demand for personalized medicine. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024-2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, and Pricing in USD
|
|
Segments Covered
|
Product Type (Software, Services), Application (Chemical Analysis, Drug Discovery, Molecular Modeling, Regulatory Compliance, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
Dassault Systèmes (France), ACD/Labs, Inc. (Canada), Agilent Technologies, Inc. (U.S.), Cambridgesoft Corp. (U.S.), ChemAxon, Inc. (Hungary), Bio-Rad Laboratories, Inc. (U.S.), Schrödinger, LLC (U.S.), Molecular Discovery Ltd. (U.K.), among others
|
|
Market Opportunities
|
|
Market Definition
Chemoinformatics combines principles from chemistry, computer science, and information technology to analyze and interpret chemical data. It involves the use of computational tools and techniques to store, retrieve, and analyze chemical information, such as molecular structures, properties, and reactions. Chemoinformatics plays a crucial role in drug discovery and development by helping researchers design and optimize new drug candidates, predict their properties and interactions, and understand their behavior in biological systems. It also aids in the management and analysis of large chemical datasets, facilitating research and decision-making in the field of chemistry.
Global Chemoinformatics Market Dynamics
Drivers
- Growing Demand for Efficient Drug Discovery
There is an increasing demand for more efficient drug discovery processes to reduce time and costs. Chemoinformatics provides tools and methods to streamline the drug discovery process, from compound screening to lead optimization, leading to faster development of new drugs.
- Advancements in Computational Power
The continuous advancements in computational power and technology have enabled more complex and sophisticated chemoinformatics analyses. This has expanded the capabilities of chemoinformatics tools, allowing for more accurate predictions and modeling in drug discovery and development.
Opportunities
- Increasing Focus on Personalized Medicine
The increasing focus on personalized medicine presents an opportunity for chemoinformatics to play a crucial role. Chemoinformatics tools can be used to analyze genetic and molecular data to develop personalized treatment regimens for patients, leading to more effective and targeted therapies.
- Emergence of AI-Driven Drug Discovery Platforms
The increasing use of artificial intelligence (AI) and machine learning (ML) in drug discovery is opening up new opportunities for chemoinformatics. AI-driven platforms can analyze large datasets more efficiently and accurately than traditional methods, leading to the discovery of novel drug candidates and therapeutic targets.
Restraints/Challenges
- High Cost Limit Adoption of Chemoinformatics Tools
The high cost of developing and implementing chemoinformatics tools and software is a significant restraint in the global market. The substantial initial investment needed for software acquisition, personnel training, and infrastructure maintenance poses a challenge, particularly for smaller research institutions and companies. This cost barrier often limits the adoption of chemoinformatics tools, especially in emerging markets or among organizations with constrained resources.
- Complex Data Integration and Interpretation
The complexity of integrating and interpreting large and diverse datasets poses a challenge for the global chemoinformatics market. Analyzing complex chemical data, such as molecular structures and properties, requires sophisticated algorithms and computational tools. Moreover, interpreting the results of chemoinformatics analyses necessitates a profound understanding of both chemistry and informatics, presenting a challenge for researchers and practitioners in the field and thus hampers the market.
This global chemoinformatics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global chemoinformatics market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.
Recent Developments
- In October 2023, Cadence Molecular Sciences (OpenEye) announced an agreement with Pfizer Inc. to extend and expand access to Cadence products and programming toolkits for advanced molecular design. Cadence Molecular Sciences' physics- and AI-based modeling and cheminformatics computational software are facilitating early-stage drug discovery innovation
Global Chemoinformatics Market Scope
The global chemoinformatics market is segmented on the basis of product type, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Software
- Services
Application
- Chemical Analysis
- Drug Discovery
- Molecular Modeling
- Regulatory Compliance
- Others
End User
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations
- Academic and Research Institutes
Global Chemoinformatics Market Regional Analysis/Insights
The global chemoinformatics market is analysed and market size insights and trends are provided by country, product type, application and end user as referenced above.
The countries covered in the global chemoinformatics market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.
North America dominates the global chemoinformatics market due to due to its strong presence of pharmaceutical and biotechnology companies, advanced research institutions, well-developed IT infrastructure, supportive regulatory environment, and high healthcare expenditure.
Asia-Pacific is expected to witness significant growth during the forecast period of 2024 to 2031 due to the region's rapidly expanding pharmaceutical and biotechnology sectors, increasing research and development activities, and growing adoption of advanced technologies.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global chemoinformatics market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global chemoinformatics market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the global chemoinformatics market. The data is available for historic period 2016-2021.
Competitive Landscape and Global Chemoinformatics Market Share Analysis
The global chemoinformatics market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the global chemoinformatics market.
Some of the major players operating in the global chemoinformatics market are:
- Dassault Systèmes (France)
- ACD/Labs, Inc. (Canada)
- Agilent Technologies, Inc. (U.S.)
- Cambridgesoft Corp. (U.S.)
- ChemAxon, Inc. (Hungary)
- Bio-Rad Laboratories, Inc. (U.S.)
- Schrödinger, LLC (U.S.)
- Molecular Discovery Ltd. (U.K.)
SKU-